Journals / Turkish Journal of Gastroenterology / 2013 / Cilt: 24 - Sayı: 2

Otoimmun hepatitli çocuk hastada assit olmadan gelişen hepatik hidrotoraksın oktreotid ve plörodez ile başarılı tedavisi

Hepatic hydrothorax in the absence of ascites in a child with autoimmune hepatitis: Successful management with octreotide and pleurodesis

Pages
178–183
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, hepatic hydrothorax should be considered in the differential diagnosis of pleural effusion oc- curring in children with cirrhotic liver, whether associated with ascites or not.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hepatic hydrothorax is a rare complication of liver cirrhosis and portal hypertension.
📊
Key Findings & Data:We report a nine-year-old child with autoimmune hepatitis type 1, who presen- ted with a right-sided hepatic hydrothorax in the absence of ascites.
💡
Conclusion & Impact:In conclusion, hepatic hydrothorax should be considered in the differential diagnosis of pleural effusion oc- curring in children with cirrhotic liver, whether associated with ascites or not.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hepatic hydrothorax is a rare complication of liver cirrhosis and portal hypertension. It carries a diagnostic and therapeutic diffi- culty especially if occurring in the absence of ascites. We report a nine-year-old child with autoimmune hepatitis type 1, who presen- ted with a right-sided hepatic hydrothorax in the absence of ascites. The patient was treated successfully with diuretics, octreotide and pleurodesis together with immunosuppressive therapy for autoimmune hepatitis. There was no recurrence of effusion after a long follow-up duration. In conclusion, hepatic hydrothorax should be considered in the differential diagnosis of pleural effusion oc- curring in children with cirrhotic liver, whether associated with ascites or not. Octreotide as a splanchnic vasoconstrictor can be used in establishing the diagnosis and in the treatment of hepatic hydrothorax. The need for liver transplantation in such patients may be avoided when the liver disease can be treated specifically.

Özet

Hepatik hidrotoraks, sirozun ve portal hipertansiyonun nadir bir komplikasyonudur. Assit olmaksızın gelişmesi halinde tanıda ve tedavide zorluklar ile karşılaşılmaktadır. Burada tip 1 otoimmun hepatiti olan 9 yaşında; assit olmadan sağ taraşı hepatik hid- rotoraks ile başvuran çocuk hasta sunulmuştur. Hasta immun supresif tedaviye ek olarak diüretikler, oktreotid ve plörodez ile ba- şarılı bir şekilde tedavi edilmiştir. Uzun süreli takip sonunda plevral effüzyon tekrar etmemiştir. Sonuç olarak, sirozlu çocuklarda hepatik hidrotoraks; beraberinde assit olsun olmasın, plevral effüzyonun ayrıcı tanısında akılda tutulmalıdır. Splanknik vazokons- triktör olan oktreotid hepatik hidrotoraksın tanısında ve tedavisinde kullanılabilir. Karaciğer hastalığı özgül olarak tedavi edile- bilir ise bu hastalarda karaciğer nakline gerek duyulmayabilir.

🔖

Cite This Article

SIRA, A. M., SIRA, M. M., BEHAIRY, B. E., BAKR, R. M., EL-HAGALY, M. A. (2013). Otoimmun hepatitli çocuk hastada assit olmadan gelişen hepatik hidrotoraksın oktreotid ve plörodez ile başarılı tedavisi. Turkish Journal of Gastroenterology, Cilt: 24 - Sayı: 2, 178–183. https://ajindex.com/articles/410495

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Cardenas A, Kelleher T, Chopra S. Review article: hepatic hydrothorax. Aliment Pharmacol Ther 2004; 20: 271-9
  2. Doraiswamy V, Riar S, Shrestha P, et al. Hepatic hydrot- horax without any evidence of ascites. ScientificWorldJour- nal 2011; 11: 587-91
  3. Roussos A, Philippou N, Mantzaris GJ, Gourgouliannis KI. Hepatic hydrothorax: pathophysiology diagnosis and ma- nagement. J Gastroenterol Hepatol 2007; 22: 1388-93
  4. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9
  5. Alvarez F, Berg PA, Bianchi FB, et al. International Auto- immune Hepatitis Group Report: review of criteria for di- agnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929- 38
  6. Gulati D, Mullen K, Magrey M. Unilateral pleural effusion- -but where from? Lancet 2010; 375: 2120
  7. Czaja AJ, Morshed SA, Parveen S, Nishioka M. Antibodies to single-stranded and double-stranded DNA in antinucle- ar antibody-positive type 1-autoimmune hepatitis. Hepato- logy 1997; 26: 567-72
  8. Scully LJ, Toze C, Sengar DP, Goldstein R. Early-onset au- toimmune hepatitis is associated with a C4A gene deletion. Gastroenterology 1993; 104: 1478-84
  9. Barreales M, Saenz-Lopez S, Igarzabal A, et al. Refractory hepatic hydrothorax: successful treatment with octreotide. Rev Esp Enferm Dig 2005; 97: 830-5
  10. Borchardt J, Smirnov A, Metchnik L, Malnick S. Treating hepatic hydrothorax. BMJ 2003; 326: 751-2
  11. Salama EI, Ehsan NA, Behairy EB, et al. Improvement of the histopathology on a maintenance regimen in children with autoimmune hepatitis. East J Med 2011; 16: 178-87
  12. Ferreira AR, Roquete ML, Toppa NH, et al. Effect of treat- ment of hepatic histopathology in children and adolescents with autoimmune hepatitis. J Pediatr Gastroenterol Nutr 2008; 46: 65-70
  13. Dumortier J, Lepretre J, Scalone O, et al. Successful treat- ment of hepatic hydrothorax with octreotide. Eur J Gastro- enterol Hepatol 2000; 12: 817-20
  14. Pfammatter R, Quattropani C, Reichen J, et al. Treatment of hepatic hydrothorax and reduction of chest tube output with octreotide. Eur J Gastroenterol Hepatol 2001; 13: 977- 80.